OTC Product Roundup: Sleep Aids
Whether due to jet lag, stress, major life events, or something else, there are a lot of issues that can cause short-term insomnia. Send patients on their way to a better night’s sleep with these OTC sleep aid recommendations.
New Drug Review: FDA Approves Lazertinib Combination Therapy for Non–Small Cell Lung Cancer
Study results show improvement in progression-free survival at 22 months.
New Drug Review: Donanemab-azbt Approved for Early Symptomatic Alzheimer Disease
It’s Time to Staunch Our Self-Inflicted Wounds
Outside forces are at play, but pharmacists must turn inward to address some challenges in their profession.
A Look Back at the Affordable Care Act
The Affordable Care Act was passed in 2010 to make health care and prescription medicine more accessible. Did it succeed?
Truth or Trend? Equipping Patients to Combat Misinformation
Pharmacists can monitor what health information circulates in mainstream media. But how can they rebut misinformation spread in private channels?
Community Pharmacists Play Key Role in Diabetes Prevention, Management
Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses how pharmacists can help with diabetes prevention and early detection in the community.
Q&A: Pharmacists Champion Nonopioid Pain Management Strategies
Melissa Durham, PharmD, MACM, reveals how pharmacists are uniquely positioned to counsel patients on nonopioid pain management.
ACIP Recommendations for Non-Respiratory Immunizations Remain Largely Unchanged | NCPA 2024
A second immunization session focused on updates in meningococcal disease, HPV, and Mpox.
Key Recommendations for 2024-2025 Respiratory Virus Season | NCPA 2024
The first of a 2-part presentation focused on vaccines for COVID-19, flu, RSV, and pneumococcal disease.
At Higher Risk, Vaccine Efficacy, Uptake Are Crucial for Older Adult Populations | IDWeek 2024
Three RSV vaccines are currently FDA approved for use in adults aged 60 or older.
As Meningococcal Disease Rates Rise, Researchers Evaluate Vaccine Efficacy | IDWeek 2024
Cases of meningococcal disease currently exceed prepandemic levels.
New Vaccines in the Pipeline: Norovirus, Lyme Disease, and Combination COVID-19–Flu | IDWeek 2024
Dozens of presentations at IDWeek 2024 focused on available immunizations, such as those for COVID-19, respiratory syncytial virus, and flu.
